You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-SARS-CoV-2 IgG antibodies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in

Recruiting
  • SARS-CoV2 Infection
  • SARS-CoV2 Antibodies
  • assessment of the anti-SARS-CoV-2 IgG antibody titer in 3-dose schedule
  • assessment of the anti-SARS-CoV-2 IgG antibody titer in 2-dose schedule
  • Bydgoszcz, Poland
    Department of Transplantology and General Surgery, Dr. A. Jurasz
Dec 15, 2021

Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study

Active, not recruiting
  • SARS-CoV2 Infection
  • SARS-CoV2 Antibodies
  • assessment of the anti-SARS-CoV-2 IgG antibody titer in 3-dose schedule
  • assessment of the anti-SARS-CoV-2 IgG antibody titer in 2-dose schedule
  • Bydgoszcz, Kujawsko-Pomorskie, Poland
    Cardiology Department, Dr. A. Jurasz University Hospital
Nov 4, 2021

IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney

Active, not recruiting
  • Kidney Transplantation
  • anti-spike SARS-CoV-2 IgG
  • Prague, Czechia
    Institute for Clinical and Experimental Medicine
Dec 16, 2021

Covid19 Trial in Kingman (VITROS Anti-SARS-CoV-2 IgG test)

Completed
  • Covid19
  • VITROS Anti-SARS-CoV-2 IgG test
  • Kingman, Arizona
    Kingman Regional Medical Center
Mar 16, 2022

Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

Completed
  • SARS-CoV-2 Vaccination
  • Liver Transplantation
  • Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
  • Roma, Italy
    Policlinico Tor Vergata
Aug 3, 2022

Covid19 Trial (Serological test for the detection of IgG anti-SARS-CoV-2)

Not yet recruiting
  • Covid19
  • Serological test for the detection of IgG anti-SARS-CoV-2
  • (no location specified)
Mar 19, 2021

Sars-Covid-19 Vaccines in Haematological Patients: Prospective

Completed
  • Hematologic Diseases
  • IgG antibodies to Sars-Cov-2
  • QuantiFERON SARS-CoV-2 test
  • Monza, Lombardia, Italy
    San Gerardo Hospital
Jan 23, 2023

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Kidney

Completed
  • COVID-19 Pandemic
  • Transplantation, Kidney
  • No intervention
  • Ostrava, Czechia
    University Hospital Ostrava
Dec 6, 2022

Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster

Terminated
  • Anti-SARS-CoV-2 Antibody Response
  • blood and saliva samples will be taken
  • Graz, Austria
    Medizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023

SARS-CoV-2 IgG and IgM Serologic Assays

Active, not recruiting
  • Covid19
  • Serologic assays for antibodies to SARS-CoV-2
  • Detroit, Michigan
    Henry Ford Health System
Dec 13, 2022

SARS CoV 2 Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Bangkok (Human IgG1 anti-SARS-CoV-2 antibody cocktail,

Completed
  • SARS CoV 2 Infection
  • SARS-CoV-2 Acute Respiratory Disease
  • Human IgG1 anti-SARS-CoV-2 antibody cocktail
  • Placebo
  • Bangkok, Thailand
    National Cancer Institute of Thailand
Jul 5, 2022

Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid

Recruiting
  • SARS-CoV-2
  • Anti COVID19 IgG Antibodies
  • Kfar Saba, Israel
    Meir Medical Center
Mar 28, 2021

Seroprevalence of Infection-induced SARS-CoV-2 Antibodies in

Recruiting
  • COVID-19
  • SARS-CoV-2 IgG Antibody testing
  • Hanoi, Vietnam
    Vietnam National Children's Hospital
May 3, 2022

COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

Completed
  • COVID-19
  • SARS-CoV-2 Infection
  • Quantitative analysis of SARS-CoV-2 antibodies
  • Cellular immunity
  • Prague, Czechia
    Institute of Health Information and Statistics of the Czech Repu
Nov 25, 2022

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2

Recruiting
  • Covid19
  • Serologic immunoassays to SARS-CoV-2 antibodies
  • Detroit, Michigan
    Henry Ford Health System
Dec 13, 2022

COVID-19, SARS CoV 2 Infection Trial in Orléans (Collection of biological samples)

Not yet recruiting
  • COVID-19
  • SARS CoV 2 Infection
  • Collection of biological samples
  • Orléans, France
    Centre Hospitalier Régional d'Orléans, France
Jul 21, 2022

COVID-19 Trial in Petach Tikva (no intervantion)

Active, not recruiting
  • COVID-19
  • no intervantion
  • Petach Tikva, Israel
    Schneider Children's Medical Center
Sep 29, 2022

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

Recruiting
  • Immunocompromised Patients
  • Data collection
  • Paris, Ile De France, France
    Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022

Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)

Not yet recruiting
  • Long COVID
  • +2 more
  • San Francisco, California
    UCSF/Zuckerberg San Francisco General Hospital
Jun 2, 2023

Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired Trial in Chicago (Assay of (1) the level of anti-spike IgG antibody,

Recruiting
  • Sarcoidosis
  • +2 more
  • Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
  • Chicago, Illinois
    Northwestern Medicine
Dec 6, 2021

SARS-CoV-2 RBD Antibody in My Duc Hospital Healthcare Workers

Completed
  • Covid19
  • Vaccine Reaction
  • SARS-CoV-2 IgG II Quant
  • Ho Chi Minh City, Tan Binh, Vietnam
    HOPE Research Center, My Duc Hospital
Aug 20, 2022

SARS-CoV-2 Antibodies Levels inVaccinated Population of Valle de

Recruiting
  • COVID-19
  • Levels of IgG and IgM SARS-CoV-2 antibodies blood test.
  • RT-PCR SARS-CoV-2 nasopharyngeal swab
  • Medellin, Antioquia, Colombia
    Laboratorio Integrado de Medicina Especializada
Feb 24, 2022

COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

Not yet recruiting
  • Follicular Lymphoma
  • Cellular immunity vs SARS-CoV-2
  • +6 more
  • Alessandria, IT, Italy
  • +13 more
Oct 10, 2023

COVID-19, SARS CoV 2 Infection Trial in Minneapolis (LumiraDX, RightSign, Case Control)

Completed
  • COVID-19
  • SARS CoV 2 Infection
  • LumiraDX
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota
Nov 18, 2022

COVID-19 Trial in Bruxelles (Evolution of antibodies titre)

Recruiting
  • COVID-19
  • Evolution of antibodies titre
  • Bruxelles, International, Belgium
    Cliniques universitaires Saint-Luc
Jan 12, 2022